Sign in
4

Changes in Ownership

TherapeuticsMD, Inc. Filed Acc 0001209191-22-046965

Director acquired 1,984 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ling Karen Director 2022-08-18 Option exercise +1,984 4,591 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ling Karen Director 2022-08-18 Option exercise · Restricted Stock Units −1,984 0 D: show line 2 in the form
Loading xslF345X03/doc4.xml…